Beta-galactosidase activity in fibroblasts and tissues from sheep with a lysosomal storage disease.
Tissues and fibroblasts of sheep affected with an inherited, neuronal lysosomal storage disease expressed a deficiency of beta-galactosidase activity. Cerebrum, kidney, lung, spinal cord, and spleen from affected sheep had less than 8% of the beta-galactosidase activity present in the respective tissues of normal sheep. No evidence for the presence of an endogenous inhibitor in affected sheep was detected by mixing studies. Liver of affected sheep expressed a deficiency of beta-galactosidase activity only in the presence of the beta-D-glycosidase inhibitors, glucono-delta-lactone and 2,5-dihydroxymethyl-3,4-dihydroxypyrrolidine. In these studies, we demonstrated the existence of tissue-specific beta-galactosidases in sheep and showed that the affected sheep have a deficiency of the lysosomal beta-galactosidase. Our results suggest that the high residual beta-galactosidase activity in liver of affected sheep can be attributed to a nonlysosomal beta-galactosidase that has a neutral pH optimum and may be under temporal regulation.
Ahern-Rindell
A J
AJ
Department of Veterinary Microbiology and Pathology, Washington State University, Pullman 99164-7040.
Murnane
R D
RD
Prieur
D J
DJ
D000818:Animals; D002239:Carbohydrate Metabolism, Inborn Errors / Q000201:enzymology / Q000662:veterinary*; D002478:Cells, Cultured; D005347:Fibroblasts / Q000201:enzymology; D005696:Galactosidases / Q000172:deficiency*; D007700:Kinetics; D009928:Organ Specificity; D012756:Sheep; D012757:Sheep Diseases / Q000201:enzymology*; D012867:Skin / Q000201:enzymology; D001616:beta-Galactosidase / Q000172:deficiency* / Q000378:metabolism
D005696:Galactosidases; D001616:beta-Galactosidase